Search research articles
Contact Us
Filters
Showing results (221-230 of 272) with videos related to
Page
of 28
Sort By:
Immunity
|
May 15, 2016
A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell Subsets
Steven D Scoville, Bethany L Mundy-Bosse, Michael H Zhang, et al.
Scientific Reports
|
December 14, 2020
Soy-tomato enriched diet reduces inflammation and disease severity in a pre-clinical model of chronic pancreatitis
Debasmita Mukherjee, Mallory J DiVincenzo, Molly Torok, et al.
Journal for Immunotherapy of Cancer
|
June 26, 2020
CD200 promotes immunosuppression in the pancreatic tumor microenvironment
Fouad Choueiry, Molly Torok, Reena Shakya, et al.
Lymphatic Research and Biology
|
December 3, 2025
Using Group Concept Mapping to Define Priorities for Lymphedema Care and Research
Sara P Myers, Min-Jeong Cho, Erin E Burke, et al.
The Journal of Biological Chemistry
|
October 27, 2016
Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells
Kavin Fatehchand, Elizabeth L McMichael, Brenda F Reader, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2016
IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells
Elizabeth L McMichael, Alena Cristina Jaime-Ramirez, Kristan D Guenterberg, et al.
Annals of Surgical Oncology
|
July 30, 2016
Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling
Nicholas Latchana, Sara E Martin Del Campo, Valerie P Grignol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2009
Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors
Pravin T P Kaumaya, Kevin Chu Foy, Joan Garrett, et al.
Cancer Immunology, Immunotherapy : CII
|
August 1, 2023
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy
Steven H Sun, Colin D Angell, Himanshu Savardekar, et al.
BMC Cancer
|
May 21, 2020
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
Robert Wesolowski, Andrew Stiff, Dionisia Quiroga, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 272) with videos related to
Sort By:
Page
of 28
Immunity
|
May 15, 2016
A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell Subsets
Steven D Scoville, Bethany L Mundy-Bosse, Michael H Zhang, et al.
Scientific Reports
|
December 14, 2020
Soy-tomato enriched diet reduces inflammation and disease severity in a pre-clinical model of chronic pancreatitis
Debasmita Mukherjee, Mallory J DiVincenzo, Molly Torok, et al.
Journal for Immunotherapy of Cancer
|
June 26, 2020
CD200 promotes immunosuppression in the pancreatic tumor microenvironment
Fouad Choueiry, Molly Torok, Reena Shakya, et al.
Lymphatic Research and Biology
|
December 3, 2025
Using Group Concept Mapping to Define Priorities for Lymphedema Care and Research
Sara P Myers, Min-Jeong Cho, Erin E Burke, et al.
The Journal of Biological Chemistry
|
October 27, 2016
Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells
Kavin Fatehchand, Elizabeth L McMichael, Brenda F Reader, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2016
IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells
Elizabeth L McMichael, Alena Cristina Jaime-Ramirez, Kristan D Guenterberg, et al.
Annals of Surgical Oncology
|
July 30, 2016
Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling
Nicholas Latchana, Sara E Martin Del Campo, Valerie P Grignol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2009
Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors
Pravin T P Kaumaya, Kevin Chu Foy, Joan Garrett, et al.
Cancer Immunology, Immunotherapy : CII
|
August 1, 2023
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy
Steven H Sun, Colin D Angell, Himanshu Savardekar, et al.
BMC Cancer
|
May 21, 2020
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
Robert Wesolowski, Andrew Stiff, Dionisia Quiroga, et al.
Page
of 28